Global Key SolutionsGKS
Guidance Documents/Guidance-Document/Premenopausal Women with Breast Cancer: Developing Drugs for Treatment: Guidance for Industry

Premenopausal Women with Breast Cancer: Developing Drugs for Treatment: Guidance for Industry

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

June 17, 2021

June 17, 2021

Office of the Commissioner

03f0e242-74ab-4a8e-b4b3-5d5c1d720852

Related Documents

Bladder Cancer: Developing Drugs and Biologics for Adjuvant Treatment: Guidance for Industry

Guidance DocumentJune 28, 2022Office of the Commissioner
View Details →

Renal Cell Carcinoma: Developing Drugs and Biologics for Adjuvant Treatment: Guidance for Industry

Guidance DocumentJune 27, 2022Office of the Commissioner
View Details →

Male Breast Cancer: Developing Drugs for Treatment: Guidance for Industry

Guidance DocumentAugust 12, 2020Office of the Commissioner
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.